Showing results (121-130 of 194) with videos related to
Sort By:
Pageof 20
Journal of Virology|October 17, 2008
Frequency and phenotype of human immunodeficiency virus envelope-specific B cells from patients with broadly cross-neutralizing antibodiesNicole A Doria-Rose, Rachel M Klein, Maura M Manion, et al.Pathogens & Immunity|April 18, 2019
Susceptibility to SIV Infection After Adenoviral Vaccination in a Low Dose Rhesus Macaque Challenge ModelIrene Bukh Brody, Roberto Calcedo, Mary J Connell, et al.Clinical Trials (London, England)|July 22, 2022
A platform trial design for preventive vaccines against Marburg virus and other emerging infectious disease threatsIra M Longini, Yang Yang, Thomas R Fleming, et al.The Journal of Infectious Diseases|December 4, 2012
Enhanced effector function of CD8(+) T cells from healthy controls and HIV-infected patients occurs through thrombin activation of protease-activated receptor 1Amanda Hurley, Mindy Smith, Tatiana Karpova, et al.Journal of Virology|October 23, 2009
Differential specificity and immunogenicity of adenovirus type 5 neutralizing antibodies elicited by natural infection or immunizationCheng Cheng, Jason G D Gall, Martha Nason, et al.Journal of Virology|November 20, 2015
Human Immunodeficiency Virus Type 1 Monoclonal Antibodies Suppress Acute Simian-Human Immunodeficiency Virus Viremia and Limit Seeding of Cell-Associated Viral ReservoirsDiane L Bolton, Amarendra Pegu, Keyun Wang, et al.The Journal of Infectious Diseases|April 18, 2026
Bacterial dysbiosis, cervicovaginal human papillomaviruses and inflammation persist in women living with HIV-1 after a year of antiretroviral treatmentAndrea Lisco, Alessandra Borgognone, Christophe Vanpouille, et al.American Journal of Epidemiology|August 21, 2025
Validating and leveraging non-SARS-CoV-2 respiratory infection as a negative control outcome in a phase 3 COVID-19 vaccine trial with extended observational follow-upEthan Ashby, Holly Janes, Dean Follmann, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 29, 2020
Patterns of signs, symptoms, and laboratory values associated with Zika, dengue, and undefined acute illnesses in a dengue endemic region: Secondary analysis of a prospective cohort study in southern MexicoSally Hunsberger, Ana M Ortega-Villa, John H Powers, et al.Open Forum Infectious Diseases|December 16, 2024
Who to Boost When: The Effect of Age and Dosing Interval on Delta and Omicron COVID-19 Incidence in the Open-label Phase of the COVE TrialDean Follmann, Xiaowei Wang, Lindsey R Baden, et al.Pageof 20